Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination pharmaceutical product developed and manufactured by Chemidrug Industries in Nepal for the management of productive cough and respiratory congestion. The formulation combines three active ingredients: bromhexine hydrochloride, a mucolytic that thins and loosens phlegm; ammonium chloride, an expectorant that increases the volume of respiratory tract secretions to facilitate clearance; and pheniramine maleate, an antihistamine that reduces allergic responses and congestion. It is primarily used to improve mucus clearance and provide symptomatic relief in patients with respiratory tract infections or conditions characterized by excessive mucus production. The product is manufactured in a WHO GMP-certified facility in Thankot, Nepal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bromhexine + ammonium chloride + pheniramine.